Skip to content

Clinical trials

Phase 1 Respiratory Syncytial Virus Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Syncytial Virus Infections Phase: Phase 1 Clear all

88 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20072
20102
20115
20121
201310
20147
20155
20165
20175
20188
20192
20204
20215
20224
20233
202411
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed70
Terminated7
Active, not recruiting4
Withdrawn3
Recruiting2
Unknown status1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)18
Enanta Pharmaceuticals, Inc9
Pfizer6
GlaxoSmithKline5
MedImmune LLC4
Ablynx, a Sanofi company3
Alios Biopharma Inc.3
MicroDose Therapeutx, Inc3
Sanofi Pasteur, a Sanofi Company3
Bavarian Nordic2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Syncytial Virus Infections88
Respiratory Tract Infections5
Virus Diseases5
Bronchiolitis1
Influenza, Human1
Paramyxoviridae Infections1

Trials

Showing 76 to 88 of 88. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.